Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 604 of 1,261
  1. US 9782437

    Methods and compositions for targeted cleavage and recombination

    Sangamo Therapeutics, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  2. US 9782428

    Method for generation of broadly neutralizing anti-pathogen antibodies

    Northwestern University · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  3. US 9783578

    Immunosuppression modulating compounds

    Aurigene Discovery Technologies Limited · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  4. US 9782488

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  5. US 9782387

    Compositions and methods for treating hematological malignancies

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  6. US 9782381

    Molecular targets for healing or treating wounds

    University College Cardiff Consultants Limited · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  7. US 9782399

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  8. US 9782382

    TOFA analogs useful in treating dermatological disorders or conditions

    Dermira (Canada), Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  9. US 9782347

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  10. US 9782402

    Injectable composition comprising buprenorphine

    Indivior UK Limited · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  11. US 9782258

    Intramyocardial patterning for global cardiac resizing and reshaping

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  12. US 9782345

    Ocular composition and method

    Jade Therapeutics, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  13. US 9783501

    Substituted quinolines as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  14. US 9782480

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  15. US 9782479

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  16. US 9782478

    Prostate-specific membrane antigen binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  17. US 9782472

    Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  18. US 9782465

    Serologic correlates of protection against Bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  19. US 9782398

    Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

    Neurocrine Biosciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  20. US 9783529

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  21. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  22. US 9783598

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  23. US 9783616

    Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs

    UNIVERSITY OF CONNECTICUT · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  24. US 9782408

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.